Literature DB >> 7913614

Chronotropic response to exercise in patients with atrial fibrillation: relation to functional state.

M P van den Berg1, H J Crijns, A T Gosselink, S A van den Broek, H J Hillege, D J van Veldhuisen, K I Lie.   

Abstract

OBJECTIVE: To determine the relation between functional capacity and heart rate response to exercise in patients with atrial fibrillation.
SUBJECTS: 73 consecutive patients with chronic atrial fibrillation. MAIN OUTCOME MEASURES: Relation between functional capacity, measured as peak oxygen consumption (peak VO2; ml/min/kg), and heart rate at all stages of exercise in univariate and multivariate analyses.
RESULTS: Peak VO2 showed no correlation with resting heart rate, but it showed a negative correlation with heart rate during the first stage of exercise (r = -0.94, p < 0.01). Indeed, heart rate during the early stages of exercise (stages 1-5) was higher in patients with a peak VO2 less than or equal to 20 ml/mm/kg than in those with a peak VO2 greater than 20 ml/min/kg (heart rate 140 v 125 beats/min, p < 0.05). At maximal exercise, however, peak VO2 was positively correlated with heart rate (r = 2.15, p < 0.0001).
CONCLUSION: In patients with atrial fibrillation and impaired functional capacity heart rate at low levels of exercise is augmented but maximal heart rate attenuated compared with patients with preserved functional capacity. Excessive heart rate responses to minor exercise may have deleterious effects on left ventricular function and thereby further limit functional capacity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7913614      PMCID: PMC1025276          DOI: 10.1136/hrt.70.2.150

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  21 in total

1.  Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure.

Authors:  C A CHIDSEY; D C HARRISON; E BRAUNWALD
Journal:  N Engl J Med       Date:  1962-09-27       Impact factor: 91.245

2.  Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation.

Authors:  R V Lewis; J McMurray; D G McDevitt
Journal:  J Cardiovasc Pharmacol       Date:  1989-01       Impact factor: 3.105

3.  Treadmill exercise in assessment of the functional capacity of patients with cardiac disease.

Authors:  J A Patterson; J Naughton; R J Pietras; R M Gunnar
Journal:  Am J Cardiol       Date:  1972-11       Impact factor: 2.778

Review 4.  Normal and abnormal heart rate responses to exercise.

Authors:  H K Hammond; V F Froelicher
Journal:  Prog Cardiovasc Dis       Date:  1985 Jan-Feb       Impact factor: 8.194

5.  Maximal exercise testing and gas exchange in patients with chronic atrial fibrillation.

Authors:  J E Atwood; J Myers; M Sullivan; S Forbes; R Friis; W Pewen; P Callaham; P Hall; V Froelicher
Journal:  J Am Coll Cardiol       Date:  1988-03       Impact factor: 24.094

6.  Effects of captopril versus milrinone therapy in modulating the adrenergic nervous system response to exercise in congestive heart failure.

Authors:  R Corbalán; J Jalil; G Chamorro; P Casanegra; P Valenzuela
Journal:  Am J Cardiol       Date:  1990-03-01       Impact factor: 2.778

7.  Effects of enalapril on myocardial noradrenaline overflow during exercise in patients with chronic heart failure.

Authors:  I P Mulligan; A G Fraser; M J Lewis; A H Henderson
Journal:  Br Heart J       Date:  1989-01

8.  Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure.

Authors:  G S Francis; S R Goldsmith; S M Ziesche; J N Cohn
Journal:  Am J Cardiol       Date:  1982-04-01       Impact factor: 2.778

9.  Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation.

Authors:  J E Atwood; M Sullivan; S Forbes; J Myers; W Pewen; H G Olson; V F Froelicher
Journal:  J Am Coll Cardiol       Date:  1987-08       Impact factor: 24.094

10.  Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure.

Authors:  K T Weber; G T Kinasewitz; J S Janicki; A P Fishman
Journal:  Circulation       Date:  1982-06       Impact factor: 29.690

View more
  2 in total

Review 1.  When, and when not, to use digoxin in the elderly.

Authors:  A T Gosselink; D J van Veldhuisen; H J Crijns
Journal:  Drugs Aging       Date:  1997-06       Impact factor: 3.923

Review 2.  Heart failure and atrial fibrillation: current concepts and controversies.

Authors:  M P Van den Berg; A E Tuinenburg; H J Crijns; I C Van Gelder; A T Gosselink; K I Lie
Journal:  Heart       Date:  1997-04       Impact factor: 5.994

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.